Regenerative Approaches and Future Trends for the Treatment of Corneal Burn Injuries.
burn injury
cornea
extracellular vesicles
imaging
stem cells
wound healing
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
16 Jan 2021
16 Jan 2021
Historique:
received:
13
12
2020
revised:
12
01
2021
accepted:
14
01
2021
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
Ocular chemical and thermal burns are frequent causes of hospitalization and require immediate interventions and care. Various surgical and pharmacological treatment strategies are employed according to damage severity. Controlling inflammation and neovascularization while promoting normal ocular surface anatomy and function restoration is the principal aim. In the most severe cases, when epithelial healing is severely affected, reconstruction of the ocular surface may be a valid option, which, however, requires expertise, adequate instruments, and qualified donors. Numerous endogenous and exogenous strategies have been considered for corneal repair. Among these, stem cells and their derivatives have offered numerous attractive possibilities in finding an effective way in stimulating corneal regeneration. Limbal epithelial stem cells and mesenchymal cells from the ocular tissue as well as from various sources have demonstrated their effectiveness in dampening neovascularization, scarring, and inflammation, while promoting epithelialization of the injured cornea. Moreover, a plethora of cytokines and growth factors, and extracellular vesicles, which constitute the secretome of these cells, work in concert to enhance wound healing. In this review, we provide an update on the recent potential therapeutic avenues and clinical applications of stem cells and their products in corneal regeneration after burn injury, as well as current imaging strategies for monitoring therapeutic efficacy and damage resolution.
Identifiants
pubmed: 33467167
pii: jcm10020317
doi: 10.3390/jcm10020317
pmc: PMC7830803
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Progetti di ricerca di Rilevante Interesse Nazionale
ID : 201572SHXJ
Organisme : Regione Piemonte
ID : EV-ER Piattaforma Tecnologica "Salute e Benessere
Organisme : Consorzio interuniversitario per Biotecnologie
ID : N/A
Organisme : Regione Piemonte
ID : POR-FES 2014-2020 - Poli di Innovazione (EPATOCARE)
Références
Cells. 2020 Feb 07;9(2):
pubmed: 32046114
Biomaterials. 2016 Jan;75:47-57
pubmed: 26480471
J Clin Med. 2019 Dec 26;9(1):
pubmed: 31888042
Invest Ophthalmol Vis Sci. 2012 Aug 03;53(9):5109-16
pubmed: 22736610
J Am Chem Soc. 2002 Mar 27;124(12):3152-62
pubmed: 11902904
Biophys Rep. 2016;2(1):1-20
pubmed: 27819026
Nat Rev Drug Discov. 2013 May;12(5):347-57
pubmed: 23584393
Radiology. 1998 May;207(2):529-38
pubmed: 9577506
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1594
pubmed: 31840427
Sci Transl Med. 2014 Dec 10;6(266):266ra172
pubmed: 25504883
Sci Rep. 2016 May 19;6:26227
pubmed: 27195722
Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5686-97
pubmed: 22836771
PLoS Biol. 2019 Jul 18;17(7):e3000363
pubmed: 31318874
Stem Cells Transl Med. 2019 Nov;8(11):1192-1201
pubmed: 31290598
Int J Mol Med. 2014 May;33(5):1055-63
pubmed: 24573178
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3638-44
pubmed: 22562508
Immunol Lett. 2003 Oct 31;89(2-3):267-70
pubmed: 14556988
Oncotarget. 2017 Dec 13;9(7):7398-7410
pubmed: 29484119
Nature. 2019 Sep 2;:
pubmed: 32868921
Stem Cells Transl Med. 2019 May;8(5):478-489
pubmed: 30644653
PLoS One. 2012;7(2):e30842
pubmed: 22363499
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):955-62
pubmed: 11923234
Eye (Lond). 2019 Sep;33(9):1362-1377
pubmed: 31086244
Stem Cells. 2009 Jul;27(7):1635-42
pubmed: 19544455
Ocul Surf. 2020 Oct;18(4):681-688
pubmed: 32735950
J Cell Sci. 2013 Sep 1;126(Pt 17):3948-60
pubmed: 23813962
Anal Chem. 2018 Oct 2;90(19):11273-11279
pubmed: 30178994
Curr Protoc Cell Biol. 2017 Jun 19;75:3.44.1-3.44.15
pubmed: 28627754
Sci Rep. 2020 Jul 24;10(1):12448
pubmed: 32709896
Angiogenesis. 2010 Jun;13(2):71-4
pubmed: 20559867
J Magn Reson Imaging. 2002 Oct;16(4):407-22
pubmed: 12353256
Prog Retin Eye Res. 2010 May;29(3):208-48
pubmed: 20100589
ACS Nano. 2017 Nov 28;11(11):10883-10893
pubmed: 28960957
J Ophthalmol. 2014;2014:196827
pubmed: 25105018
Ocul Surf. 2019 Jul;17(3):400-411
pubmed: 30959113
Results Probl Cell Differ. 2012;55:357-94
pubmed: 22918816
Theranostics. 2019 May 31;9(13):3812-3824
pubmed: 31281515
N Engl J Med. 2017 Mar 16;376(11):1047-1053
pubmed: 28296617
Mol Cells. 2018 Feb 28;41(2):93-102
pubmed: 29429150
Circ Res. 2019 Dec 6;125(12):1038-1051
pubmed: 31594470
Sci Rep. 2019 Aug 23;9(1):12331
pubmed: 31444394
Clin Exp Optom. 2013 Jul;96(4):400-21
pubmed: 23051047
Hum Gene Ther. 2015 Oct;26(10):698-707
pubmed: 26165705
Cancers (Basel). 2020 Nov 03;12(11):
pubmed: 33153067
Adv Emerg Nurs J. 2017 Jul/Sep;39(3):193-198
pubmed: 28759511
Cells. 2020 Sep 26;9(10):
pubmed: 32993109
Mol Vis. 2019 Aug 07;25:415-426
pubmed: 31523119
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5507-5517
pubmed: 29075761
J Clin Med. 2020 Feb 06;9(2):
pubmed: 32041096
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):251-265
pubmed: 30302506
Nanomaterials (Basel). 2020 Sep 28;10(10):
pubmed: 32998422
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Mol Biol Cell. 2002 Dec;13(12):4279-95
pubmed: 12475952
Sci Rep. 2015 Nov 04;5:16186
pubmed: 26531048
ACS Appl Mater Interfaces. 2018 Aug 8;10(31):26056-26063
pubmed: 30011179
Nat Commun. 2019 Apr 3;10(1):1496
pubmed: 30944320
J Clin Med. 2019 Dec 14;8(12):
pubmed: 31847319
Eye (Lond). 2006 Apr;20(4):482-90
pubmed: 15895027
Sci Rep. 2015 Oct 26;5:15636
pubmed: 26497063
J Control Release. 2015 Feb 10;199:145-55
pubmed: 25523519
Curr Opin Hematol. 2006 Nov;13(6):419-25
pubmed: 17053453
Br J Ophthalmol. 2020 Feb;104(2):247-253
pubmed: 31118185
Int J Mol Sci. 2017 Aug 28;18(9):
pubmed: 28846661
Curr Eye Res. 2020 Mar;45(3):265-277
pubmed: 31280624
J Clin Med. 2020 Feb 06;9(2):
pubmed: 32041213
Br J Ophthalmol. 2020 Mar;104(3):404-409
pubmed: 31142464
Cells. 2019 Oct 11;8(10):
pubmed: 31614642
Pharmacol Ther. 2020 Jul;211:107550
pubmed: 32325067
Stem Cells Transl Med. 2020 Jan;9(1):39-46
pubmed: 31411820
Int J Mol Sci. 2017 Jun 12;18(6):
pubmed: 28604651
Stem Cell Res Ther. 2018 Mar 9;9(1):63
pubmed: 29523213
Mol Med Rep. 2018 Sep;18(3):3203-3210
pubmed: 30066863
Magn Reson Med. 2015 Jul;74(1):266-271
pubmed: 25052384
Cells. 2020 Sep 29;9(10):
pubmed: 33003285
Int J Mol Sci. 2019 Apr 03;20(7):
pubmed: 30987108
Prog Retin Eye Res. 2015 Nov;49:17-45
pubmed: 26197361
Stem Cells. 2006 Feb;24(2):315-21
pubmed: 16109757
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3475-84
pubmed: 15452052
Sci Rep. 2019 Jul 3;9(1):9596
pubmed: 31270454
Minerva Med. 2020 Dec 02;:
pubmed: 33263376
Int J Nanomedicine. 2018 Nov 23;13:7905-7913
pubmed: 30538467
Exp Eye Res. 2019 Sep;186:107709
pubmed: 31238077
Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):992-1000
pubmed: 19057023
Int J Mol Sci. 2019 Jun 12;20(12):
pubmed: 31212734
Br J Ophthalmol. 2001 Nov;85(11):1379-83
pubmed: 11673310